However, OICR-9429 did not change the expression of both MLL1 and c-Myc in PCa cells, suggesting OICR-9429 may play pharmacological actions by blocking the interaction of WDR5 with MLL1 and c-Myc (Figure S13). The gene discussed is KMT2A; the disease is posterior cortical atrophy.